Lanean...
Canagliflozin attenuates the progression of atherosclerosis and inflammation process in APOE knockout mice
Abstract Background Sodium glucose co-transporter2 inhibitors reduce the incidence of cardiovascular events in patients with type 2 diabetes mellitus based on the results of recent cardiovascular outcome studies. Herein, we investigated the effects of long-term treatment with canagliflozin on bioche...
Gorde:
| Egile Nagusiak: | , , , , , , , , |
|---|---|
| Formatua: | Artigo |
| Hizkuntza: | Inglês |
| Argitaratua: |
BMC
2018-07-01
|
| Saila: | Cardiovascular Diabetology |
| Gaiak: | |
| Sarrera elektronikoa: | http://link.springer.com/article/10.1186/s12933-018-0749-1 |
| Etiketak: |
Etiketa erantsi
Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!
|